Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Cong... ( Bruker Dalto...)

Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008

Date:8/17/2008

Bruker Daltonics today is showcasing several new high performance mass spectrometry products and applications for proteomics at the 7th HUPO World Congress 2008:

AMSTERDAM, The Netherlands (Business Wire EON) August 17, 2008 -- maXis™ is the world's first high speed Ultra High Resolution TOF (UHR-TOF) mass spectrometer platform, and truly represents a revolution in tandem mass spectrometry. maXis offers exceptional proteomics performance with sub-ppm mass accuracy, mass resolution of 40,000 to 60,000 across a broad mass range, outstanding sensitivity and five orders of dynamic range - all at the high spectral rate of 20 Hz for MS and MS/MS that is essential for quantitative proteomics and to take full advantage of ultra-high performance liquid chromatography. ETD II is the next-generation electron transfer dissociation module for Bruker's HCTultra™ high capacity ion trap. It is based on a novel and compact nCI (negative chemical ionization) source with increased ETD/PTR reactant ion generation, resulting in rapid, confident characterization of PTMs such as phosphorylations or glycosylations at sub-fmol sensitivity. In combination with the major and fundamental ETD efficiency and sensitivity advantages of the spherical high capacity trap design, ETD II is designed to provide the most sensitive, fastest and most robust ETD fragmentation. Due to HCTultra's inherent m/z range of greater 3,000 and its superior mass resolution that can resolve 3+ and 4+ charge states of peptides on-the-fly at full analytical speed, ETD/PTR on the HCT-Ultra can even be used for up to 12 kDa proteins and beyond. MALDI-TDS™ Top-Down Sequencing (TDS) solution provides unparalleled levels of information from undigested proteins in pharmaceutical and biotechnology applications, including C- and N- terminal assignments even in the case of N-terminally blocked proteins. MALDI-TDS is available on Bruker's top-of-
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Zix Corporation Announces Webcast Showcasing Email Encryption Competitive Replacement
2. Better Nutrition Announces Best Of Beauty Awards Winners Showcasing the Best Natural Beauty Products of 2008
3. NIH scientists find a novel mechanism that controls the development of autoimmunity
4. Sales of Emerging Novel Pain Therapies Will Represent More than One-Fifth of the Total Pain Drug Market by 2023
5. Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
6. Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes
7. Finding suggests novel ways to boost vaccination or natural defenses
8. Novel hydrogel systems for dentin regeneration
9. HighPoint Solutions Develops Novel Incentive Compensation Plan for New Benign Prostatic Hyperplasia (BPH) Product
10. Novel model of osteosarcoma
11. Novel DNA microarray chip predicts functional impairment and remission in rheumatoid arthritis

Post Your Comments:

Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Cong...( Bruker Dalto...),Health